Pharmafile Logo
Pharmafocus logo
Advanced Search

UK

Showing 15 posts of 472 posts found.

RPSGB Neal

RPSGB appoints Neal Patel Head of Corporate Communications

November 30, 2009
Sales and Marketing NHS, UK, appointment, rpsgb

The Royal Pharmaceutical Society of Great Britain (RPSGB) has appointed Neal Patel as head of corporate communications.Neal will join the …

Appointment

Roche quits ABPI

June 30, 2009
Research and Development, Sales and Marketing ABPI, Roche, UK

Roche is to give up its ABPI membership in a surprise move that could undermine the UK’s system of industry …

News

A new approach to CRO partnerships

April 6, 2009
Research and Development Pfizer, UK, clincal, partnerships

Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …

Feature

The Pharmafocus interview: Simon Jose

February 20, 2009
Sales and Marketing GlaxoSmithKline, Simon Jose, UK, partnerships, pricing

Like all his contemporaries in the UK, Simon Jose, GlaxoSmithKline’s head of UK   operations has to focus on some of …

Feature

The Pharmafocus Interview: David Gillen

February 3, 2009
Research and Development Pfizer, UK, medicines access

David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …

Feature

Working Life: Sam Knivett

January 23, 2009
Business Services, Research and Development Pfizer, UK, WL, Working Life, careers, compliance, drug safety

How did you find your way into your current role?From the age of 11 I wanted to be a farmer. …

Feature

UK Biotech: time for bold and affirmative action

January 22, 2009
Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …

Feature

Declaring doctor payments

December 16, 2008
Research and Development, Sales and Marketing ABPI, EFPIA, Europe, UK, US, ethics, industry relations, payments

A number of pharmaceutical companies in the US have recently announced they will declare all the payments to healthcare professionals. …

Feature

Working Life: Philip Sarbutt

October 28, 2008
Research and Development, Sales and Marketing UK, Wyeth, Wyeth Pharmaceuticals, outsourcing

How did you find your way into your role?

Feature

Working Life: Dr Zubair Hussain

October 13, 2008
Business Services, Research and Development, Sales and Marketing Pfizer, UK, careers, recruitment, reg affairs

How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …

Feature

Overcoming barriers to access

September 30, 2008
Sales and Marketing Europe, UK, market access, strategies

Feature

Working Life: Elizabeth Stiff

September 5, 2008
Business Services, Research and Development Abbott, UK, Working Life, clinical operations

Feature

Living with the Code of Practice

September 4, 2008
Medical Communications, Sales and Marketing ABPI, UK, code, marketing, pharma

The 2008 edition of the ABPI Code of Practice came into force on 1 July and the industry is fairly …

Feature

Close to home: the UK’s regional NHS influencers

June 3, 2008
Sales and Marketing NICE, UK, healthcare, influencers, regional

With so much attention directed at NICE since the parliamentary health select committee reported on the organisation in January, it …

Feature

A sea of paperwork or business as usual?

April 30, 2008
Medical Communications, Sales and Marketing 2008, ABPI, UK, code, marketing, pharma

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026